Medical Affairs Consultant

Dr. Thomas Ramezani

Services

Strategic medical affairs support for pharmaceutical and biotech companies. Specialized in launch preparation, KOL engagement, and building medical capabilities from the ground up.

Launch Preparation

Medical strategy development, pre-launch planning, and cross-functional alignment for successful market entry.

Identification, mapping, and strategic engagement of key opinion leaders. Advisory board planning and execution.

MSL Team Development

Building, training, and leading field medical teams. Scientific communication and field excellence programs.

Medical Strategy

Medical affairs strategy, gap analysis, evidence generation planning, and lifecycle management support.

Congress Support

Scientific presence at medical congresses, booth support, session summaries, KOL meetings.

AdBoard Execution

Planning, execution, moderation, and documentation of national and regional advisory boards.

Medical Education

Development of scientific training materials, speaker preparation, slide deck creation.

Scientific Communication

Medical content review, publication support, abstracts, posters, manuscripts.

Clinical Trial Support

Site identification and feasibility, investigator relationships, enrollment optimization.

Profile

Medical Affairs professional with 9 years of experience in the pharmaceutical industry and a scientific background in oncology, immunology, and wound healing. (PhD from University of Cologne, Postdoctoral fellowship at University of Edinburgh, multiple peer-reviewed publications).

Focus on build-up and launch situations: At Madrigal Pharmaceuticals, from early pre-launch through to the market introduction of resmetirom – the first approved treatment for MASH – sole responsibility for Medical Affairs in the DACH region over 3 years. Built the regional KOL network, established and led the MSL team, and represented the German affiliate in global launch activities.

Previously at BeiGene and Clovis Oncology, building Medical Affairs for the German market from the ground up. Additional post-launch experience at Celgene.

Experience

"I've built Medical Affairs functions from the ground up in small, agile teams – and led them through successful product launches. I bring that same hands-on, resourceful approach to every client engagement."

"Results-driven and self-directed – give me a deadline and a goal, and I love to deliver."

2022 – 2026
Associate Medical Director / Senior Medical Advisor
Madrigal Pharmaceuticals

Led Medical Affairs activities in the DACH region from pre-launch through market introduction of resmetirom for MASH. Built KOL network, established and led MSL team, represented German affiliate in global launch activities.

2020 – 2022
Scientific Advisor / Medical Science Liaison
BeiGene

Part of a small team establishing Medical Affairs for the German oncology market. KOL engagement, scientific communication, and cross-functional support.

2018 – 2020
Medical Science Liaison
Clovis Oncology

Field-based medical affairs in oncology. KOL engagement, advisory boards, clinical study support, and scientific training.

2017 – 2018
Regional Medical Liaison
Celgene

Medical education, KOL relationships, and scientific communication in inflammation and immunology.

Education

  • Postdoctoral Research Fellow
    University of Edinburgh,
    MRC Centre for Inflammation Research
    2013 – 2016

  • PhD in Developmental Biology
    University of Cologne
    2009 – 2012

  • Diploma in Biology
    University of Cologne
    2003 – 2008

Contact

Get in touch:

  • EMAIL
    thomas@ramezani-medaffairs.de

  • PHONE
    +49 176 726 784 30

  • LINKEDIN
    linkedin.com/in/thomasramezani

Location

Hürth, Germany
Available for projects across EU